TORONTO, Oct. 21, 2019 – Trulieve Cannabis Corp. (“Trulieve”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States, is pleased to be added to the OTCQX Cannabis Index (.OTCQXMJ) – the performance benchmark for cannabis companies trading on the OTCQX Best Market.
The OTCQX Cannabis Index highlights a diverse group of high-quality cannabis companies that meet the financial, disclosure and corporate governance standards required to trade on the OTCQX Best Market. “This is the latest milestone in the growth of Trulieve,” said CEO Kim Rivers. “Becoming a part of the OTCQX Cannabis Index will bring a further focus on our business and operations as we continue to expand and evolve, while maintaining our commitment to a premium customer experience.”
Trulieve is a vertically integrated “seed-to-sale” company and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve also operates in California, Massachusetts and Connecticut. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX Best Market under the symbol TCNNF.
This press release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or the securities laws of any state of the United States and may not be offered or sold within the United States (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.
To learn more about Trulieve, visit www.Trulieve.com.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
SOURCE Trulieve Cannabis Corp.
For further information: Lynn Ricci, Director of Investor Relations, 1-850-270-5691, firstname.lastname@example.org